[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212 220 6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 74, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 35, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 997010, "exercisedValue": 0, "unexercisedValue": 164999}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 638607, "exercisedValue": 0, "unexercisedValue": 51561}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 703319, "exercisedValue": 0, "unexercisedValue": 61875}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 67, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 307535, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Brandi L. Roberts CPA, M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Mack", "title": "Senior Vice President of Pharmaceutical Development & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Calitri", "title": "Vice President of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stephanie  Fagan", "title": "Chief Corporate Affairs Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gregg  Pratt Ph.D.", "title": "Chief Regulatory & Quality Assurance Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 4, "overallRisk": 4, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.39, "open": 13.4, "dayLow": 13.25, "dayHigh": 14.43, "regularMarketPreviousClose": 13.39, "regularMarketOpen": 13.4, "regularMarketDayLow": 13.25, "regularMarketDayHigh": 14.43, "payoutRatio": 0.0, "beta": 3.312, "forwardPE": -10.364964, "volume": 4829224, "regularMarketVolume": 4818243, "averageVolume": 1643173, "averageVolume10days": 2263960, "averageDailyVolume10Day": 2263960, "bid": 14.15, "ask": 14.26, "bidSize": 1, "askSize": 19, "marketCap": 1380512512, "fiftyTwoWeekLow": 4.7, "fiftyTwoWeekHigh": 14.43, "allTimeHigh": 86.55, "allTimeLow": 0.015, "fiftyDayAverage": 11.0896, "twoHundredDayAverage": 8.3048, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 938646784, "profitMargins": 0.0, "floatShares": 70203301, "sharesOutstanding": 97219193, "sharesShort": 10063593, "sharesShortPriorMonth": 10692593, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.13229999, "heldPercentInsiders": 0.00784, "heldPercentInstitutions": 0.55856997, "shortRatio": 5.27, "shortPercentOfFloat": 0.1333, "impliedSharesOutstanding": 76087943, "bookValue": 2.446, "priceToBook": 5.805396, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -114517000, "trailingEps": -1.34, "forwardEps": -1.37, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "enterpriseToEbitda": -7.176, "52WeekChange": 1.3432343, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 14.2, "targetHighPrice": 55.0, "targetLowPrice": 16.0, "targetMeanPrice": 24.90909, "targetMedianPrice": 21.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 182992992, "totalCashPerShare": 2.405, "ebitda": -130802496, "totalDebt": 41191000, "quickRatio": 4.821, "currentRatio": 4.983, "debtToEquity": 22.217, "returnOnAssets": -0.30548, "returnOnEquity": -0.59114, "freeCashflow": -72089376, "operatingCashflow": -101560000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketTime": 1761940802, "exchange": "NMS", "messageBoardId": "finmb_631045282", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1761955195, "marketState": "CLOSED", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "regularMarketChangePercent": 6.04929, "regularMarketPrice": 14.2, "earningsTimestamp": 1762459200, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1762464600, "earningsCallTimestampEnd": 1762464600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.34, "epsForward": -1.37, "epsCurrentYear": -1.77111, "priceEpsCurrentYear": -8.0175705, "fiftyDayAverageChange": 3.1104002, "fiftyDayAverageChangePercent": 0.28047904, "twoHundredDayAverageChange": 5.8952, "twoHundredDayAverageChangePercent": 0.7098545, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-27", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "postMarketChangePercent": -0.00070518174, "postMarketPrice": 14.1999, "postMarketChange": -0.0001001358, "regularMarketChange": 0.809999, "regularMarketDayRange": "13.25 - 14.43", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1643173, "fiftyTwoWeekLowChange": 9.5, "fiftyTwoWeekLowChangePercent": 2.0212767, "fiftyTwoWeekRange": "4.7 - 14.43", "fiftyTwoWeekHighChange": -0.2300005, "fiftyTwoWeekHighChangePercent": -0.01593905, "fiftyTwoWeekChangePercent": 134.32343, "dividendDate": 1582761600, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1479220200000, "displayName": "Mind Medicine (MindMed)", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]